Medical Advocates

Tenofovir Disoproxil Fumarate
(Viread)
   
Journal Efficacy Citations


HBV
HDV
HIV
Genital Herpes


 


Journal  Main Page Main New/Newsworthy  Home Page      

Last Update:  April 28, 2018
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader


Hepatitis B
 

 

Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana.
Villa G, Phillips RO, Smith C, et al
J Infect. 2018 Apr 24
Abstract

Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers.
Shaheen AA, AlMattooq M, Yazdanfar S, et al
Aliment Pharmacol Th
er
. 2017 Jul 13. 
Abstract

Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance.
Lee S, Ahn SH, Jung KS, Kim DY

 J Viral Hepat
.
2016 Oct 20. doi
Abstract

Comparative renal safety assessment of the hepatitis B drugs, adefovir, tenofovir, telbivudine and entecavir in rats.
Uteng M, Mahl A, Beckmann N,
Toxicol Sci. 2016 Oct 13.
Abstract

Value of Cystatin C-Based e-GFR Measurements to Predict Long-Term Tenofovir Nephrotoxicity in Patients With Hepatitis B.
Koksal AR, Alkim H, Boga S, et al
Am J Ther. 2016 Oct 4
Abstract

FULL-TEXT ARTICLE
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Yim HJ.
Clin Mol Hepatol. 2016 Jun;22(2):238-40.
Paper

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial.
Sriprayoon T, Mahidol C, Ungtrakul T,  et al
Hepatol Res
. 2016 May 13.
Abstract

FULL-TEXT ARTICLE
Efficacy of entecavir and tenofovir in chronic hepatitis B under treatment in the public health system in southern Brazil.
Pereira CV, Tovo CV, Grossmann TK, et al
Mem Inst Oswaldo Cruz. 2016 Apr;111(4):252-7.
Paper

Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis.
Goyal SK, Dixit VK, Shukla SK,  et al
Indian J Gastroenterol. 2015 Aug 6

Abstract

Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
Fong TL, Tien A, Jo KJ,  et al

Dig Dis Sc
i
. 2015 Jul 3.
Abstract

FULL-TEXT ARTICLE
Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients
Cho EJ, Lee JH, Cho Y,  et a
PLoS One. 2015 Jun 29;10(6):e0130392
Paper

Efficacy of Tenofovir-Based Rescue Therapy in Lamivudine-Resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination.
Park JH, Jung SW, Park NH, et al 
Clin Ther. 2015 May 5.
Abstract

Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance.
Cho HJ, Kim SS, Shin SJ,  et al

J Med Virol
. 2015 May 4.
Abstract

Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial.
Lim YS, Yoo BC, Byun KS, et al
Gut. 2015 Mar 23. pii: gutjnl-2014-308435.
Abstract

Tenofovir versus entecavir in the treatment of chronic hepatitis B with severe acute exacerbation.
Hung CH, Hu TH, Lu SN,  et al

Antimicrob Agents Chemother
. 2015 Mar 16. 
Abstract

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years.
Buti M, Fung S, Gane E,  et al
Hepatol Int. 2015 Mar 13.
Abstract

Effect of Entecavir and Tenofovir Treatment on Noninvasive Fibrosis Scores: Which One Is Better?
Koksal AR, Alkim H, Boga S, et al
Am J Ther. 2015 Feb 2

Abstract

FULL-TEXT ARTICLE
Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
Kim JH, Lee JS.

Korean J Intern Med
. 2015 Jan;30(1):23-6.
Paper

FULL-TEXT  ARTICLE
Comparison of the efficacy of tenofovir disoproxil fumarate and entecavir for initial treatment of patient with chronic hepatitis B in China.
Huang M, Jie Y, Shi H, et al
Int J Clin Exp Med. 2015 Jan 15;8(1):666-73
Paper

Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients.
Kim HJ, Cho JY, Kim YJ, et al
Korean J Intern Med. 2015 Jan;30(1):32-41.
Abstract

Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial.
Lim YS, Byun KS, Yoo BC,  et al

Gut
. 2015 Jan 16. pii: gutjnl-2014-308353
Abstract

Effect of tenofovir with and without interferon on HDV replication in HIV-HBV-HDV infected patients.
Boyd A, Miailhes P, Brichler S, Scholtès C, et al
AIDS Res Hum Retroviruses
. 2013 Aug 25
Abstract

Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
Buti M, Homs M.
Expert Rev Gastroenterol Hepatol. 2012 Aug;6(4):413-21.
Abstract

Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection.
Seto WK, Yuen MF, Fung J, Lai CL.
Hepatol Int. 2011 Jun 19
Abstract

Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient
with chronic hepatitis B and without genotypic hepatitis B virus resistance.
Sarrecchia C, Svicher V, Volpi A,  et al
Infection
. 2011 Jun 15
Abstract

Comparison of the efficacy of tenofovir and adefovir in the treatment of chronic hepatitis B:
A Systematic review.
Zhao SS, Tang LH, Dai XH, et al
Virol J. 2011 Mar 9;8(1):111.
Abstract
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with
decompensated chronic hepatitis B liver disease.
Liaw YF, Sheen IS, Lee CM,   et al
Hepatology
. 2011 Jan;53(1):62-72.
Abstract

Efficacy and safety of entecavir and/or tenofovir for prophylaxis and treatment of hepatitis B
recurrence post-liver transplant.
Jiménez-Pérez M, Sáez-Gómez AB, Mongil Poce L, et al
Transplant Proc
. 2010 Oct;42(8):3167-8.
Abstract

Tenofovir is effective as monotherapy or in combination with emtricitabine in adefovir
treated patients with chronic hepatitis B infection.
Berg T, Marcellin P, Zoulim F, et al
Gastroenterology
. 2010 Jun 20
Abstract

 

Hepatitis D
 

  Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients.
Soriano V, Vispo E, Sierra-Enguita R,  et al

AIDS
.
2014 Aug 7.
Abstract

Genital Herpes
 

  Daily Oral Tenofovir and Emtricitabine-Tenofovir Preexposure Prophylaxis Reduces Herpes Simplex Virus Type 2 Acquisition Among Heterosexual HIV-1-Uninfected Men and Women: A Subgroup Analysis of a Randomized Trial.
Celum C, Morrow RA, Donnell D,  et al
A
nn Intern Med
. 2014 Jul 1;161(1):11-19.
Abstract

Vaginally Delivered Tenofovir Disoproxil Fumarate Provides Greater Protection than Tenofovir against Genital Herpes in a Murine Model of Efficacy and Safety.
Nixon B, Jandl T, Teller RS,  et al
Antimicrob Agents Chemother. 2013 Dec 9.
Abstract



Journal  Main Page Main New/Newsworthy  Home Page      

Tenofovir Efficacy
Journal Citations